The estimated Net Worth of Jerry S Lanchbury is at least $17.7 Milion dollars as of 23 September 2021. Jerry Lanchbury owns over 200 units of Myriad Genetics stock worth over $7,582,174 and over the last 21 years he sold MYGN stock worth over $7,415,048. In addition, he makes $2,685,750 as Chief Scientific Officer at Myriad Genetics.
Jerry has made over 52 trades of the Myriad Genetics stock since 2006, according to the Form 4 filled with the SEC. Most recently he sold 200 units of MYGN stock worth $7,012 on 23 September 2021.
The largest trade he's ever made was exercising 100,000 units of Myriad Genetics stock on 3 August 2021 worth over $2,599,000. On average, Jerry trades about 15,093 units every 57 days since 2003. As of 23 September 2021 he still owns at least 288,515 units of Myriad Genetics stock.
You can see the complete history of Jerry Lanchbury stock trades at the bottom of the page.
Dr. Jerry S. Lanchbury Ph.D., is the Chief Scientific Officer of Myriad Genetics, Inc. He joined the Company in September 2002 as Senior Vice President of Research. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named to his current position in February 2010. Dr. Lanchbury came to us from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.
As the Chief Scientific Officer of Myriad Genetics, the total compensation of Jerry Lanchbury at Myriad Genetics is $2,685,750. There are 2 executives at Myriad Genetics getting paid more, with R. Bryan Riggsbee having the highest compensation of $3,138,980.
Jerry Lanchbury is 60, he's been the Chief Scientific Officer of Myriad Genetics since 2010. There are 11 older and 14 younger executives at Myriad Genetics. The oldest executive at Myriad Genetics, Inc. is Walter Gilbert, 87, who is the Independent Vice Chairman of the Board.
Jerry's mailing address filed with the SEC is 320, Wakara Way, U of U Research Park, Salt Lake City, Salt Lake County, Utah, 84108, United States.
Over the last 22 years, insiders at Myriad Genetics have traded over $51,783,466 worth of Myriad Genetics stock and bought 61,160 units worth $1,252,955 . The most active insiders traders include Jerry S Lanchbury, Peter D Meldrum oraz Arthur H Jr Hayes. On average, Myriad Genetics executives and independent directors trade stock every 18 days with the average trade being worth of $563,312. The most recent stock trade was executed by Heinrich Dreismann on 9 September 2024, trading 10,000 units of MYGN stock currently worth $270,500.
myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.
Myriad Genetics executives and other stock owners filed with the SEC include: